| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Celano Michael is a Chief Financial Officer at Larimar Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 4 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | LRMR Larimar Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $3.73 | $18,631.50 | +4.6% | +13.3% | +101.4% | |
| Sep 16, 2022 | LRMR Larimar Therapeutics, Inc. | Chief Financial Officer | Buy | 31,746 | $3.15 | $99,999.90 | New | +42.5% | +32.5% | |
| Aug 12, 2022 | OSUR Orasure Technologies Inc | Director | Buy | 12,000 | $4.49 | $53,916.00 | +12.0% | +6.8% | +43.2% | |
| May 5, 2017 | OSUR Orasure Technologies Inc | Director | Sell | 44,962 | $14.95 | $672,181.90 | -54.1% | - | - | |
| Mar 2, 2017 | OSUR Orasure Technologies Inc | Director | Sale+OE | 15,000 | $12.00 | $180,000.00 | -15.3% | - | - | |
| Feb 9, 2017 | OSUR Orasure Technologies Inc | Director | Sell | 10,000 | $10.06 | $100,600.00 | -10.7% | - | - | |
| Jan 31, 2017 | OSUR Orasure Technologies Inc | Director | Sale+OE | 15,000 | $8.78 | $131,700.00 | -13.9% | - | - |